Evaluating Parental Influences on Obesity Among Mexican American Children
NCT ID: NCT00542672
Last Updated: 2013-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
831 participants
OBSERVATIONAL
2008-08-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Loss of a Healthy Weight Advantage Among Mexican-American Children
NCT03261882
Family Intervention to Prevent Childhood Obesity
NCT05606731
Family-based Outcome Results
NCT04132245
Reducing Maternal Stress to Improve Obesity-related Parenting Practices
NCT05032430
Niños Sanos, Familia Sana - A Multi-Intervention Program to Prevent Childhood Obesity in Mexican-Heritage Children in Rural California
NCT01900613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will enroll Mexican-American children and their parents. All study visits will occur at the participant's home. At a baseline visit, study staff will conduct a 1-hour interview with children and their parents to collect information on their thoughts about food, family eating habits, and how family members talk about food; children will also be asked about their physical development and physical activity level. Both parents and children will have their height, weight, waist, and hip circumference measured. Children will then wear an activity monitor for 3 days in the week following the baseline visit to measure physical activity levels. Two additional study visits will occur over the following 3 weeks. At the second visit, study staff will conduct 20-minute interviews with parents and children about their eating habits. At the third visit, study staff will videotape the child's evening meal, and additional interviews will occur. Follow-up visits will occur at Years 1 and 2. At both follow-up visits, repeat baseline interviews will occur, and children will wear the activity monitor for 3 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 8 to 10
* Only one child from each family will be eligible to participate; one child will be randomly selected if multiple children are eligible
* Mexican American
* Any marital status
* Speaks Spanish or English
* Family will be eligible to participate even if only mother agrees to participate
Exclusion Criteria
* Currently participating in another obesity clinical trial
8 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeanne M. Tschann, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, San Francisco
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1397
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.